Boothbay Fund Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,608
| Closed | -$43.2K | – | 1508 |
|
|
2024
Q4 | $43.2K | Buy |
+23,608
| New | +$43.2K | ﹤0.01% | 1207 |
|
|
2022
Q4 | – | Sell |
-14,283
| Closed | -$83K | – | 2046 |
|
|
2022
Q3 | $83K | Buy |
+14,283
| New | +$83K | ﹤0.01% | 1786 |
|
|
2020
Q2 | – | Sell |
-19,800
| Closed | -$61K | – | 956 |
|
|
2020
Q1 | $61K | Buy |
+19,800
| New | +$61K | 0.01% | 676 |
|
|
2016
Q3 | – | Sell |
-13,080
| Closed | -$92K | – | 702 |
|
|
2016
Q2 | $92K | Buy |
+13,080
| New | +$92K | 0.04% | 417 |
|